Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication
Clinical trial NCT06168214 · RECRUITING
Trial details
- NCT number
- NCT06168214
- Sponsor
- Xijing Hospital of Digestive Diseases
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-04
- Primary completion
- 2024-11-25
- Enrollment
- 1404
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.